Recursion Projects 2028 Runway, Holds 2026 Expenses Below $390M
Recursion Pharmaceuticals projects its operational runway into early 2028 while committing to keep 2026 cash operating expenses under $390 million, driven by...

Recursion Pharmaceuticals projects its operational runway into early 2028 while committing to keep 2026 cash operating expenses under $390 million, driven by...

Investors seeking income from the gold sector are increasingly turning to dividend-paying ASX gold stocks. This analysis highlights the top five performers...

Major US stock indexes surged Wednesday, led by the S&P 500 reaching a new record, as falling oil prices fueled optimism for...
Samsung Electronics' valuation soared to $1 trillion, driven by robust demand for its artificial intelligence chips. The South Korean tech giant's profits...

Hisense, a global home appliance brand, achieved a 38% sales uplift in Western Europe, driven by NIQ’s AI-powered market intelligence. This collaboration...

Emerson Electric Co. updates its 2026 sales growth forecast to 4.5% and projects $6.45-$6.55 EPS, citing strong underlying orders and market demand.

Soybean futures fell on Tuesday, with nearby contracts leading declines of up to 11 ¾ cents, despite U.S. planting progress outpacing the...

Lumen Technologies projects free cash flow between $1.9 billion and $2.1 billion by 2026, alongside announcing its intent to acquire software firm...

Logitech (LOGI) expects Q1 FY27 net sales to grow 2% to 4%, driven by increased investments in AI and business-to-business segments.